Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2013 Dec 2;123(12):5410. doi: 10.1172/JCI74035

Predicting time to ovarian carcinoma recurrence using protein markers

Ji-Yeon Yang, Kosuke Yoshihara, Kenichi Tanaka, Masayuki Hatae, Hideaki Masuzaki, Hiroaki Itamochi; The Cancer Genome Atlas (TCGA) Research Network, Masashi Takano, Kimio Ushijima, Janos L Tanyi, George Coukos, Yiling Lu, Gordon B Mills, Roel GW Verhaak
PMCID: PMC3859409

Original citation: J Clin Invest. 2010;123(9):3740–3750. doi:10.1172/JCI68509.

Citation for this erratum: J Clin Invest. 2013;123(12):5410. doi:10.1172/JCI74035.

Some expressions and notations related to Equations 1 and 2 were presented incorrectly. The correct text and equations are below.

The coefficients (β) in Cox’s regression model are estimated by maximizing the partial likelihood function subject to a constraint on the L1-norm of the coefficients. The lasso estimator (β̂) maximizes the objective function given below:

graphic file with name JCI74035.e1.jpg

(Equation 1)

Here l(β) is the log partial likelihood in the Cox model; for the exact form of this function, see ref. 41. The tuning parameter, λ in Equation 1, was chosen by 10-fold cross-validation. For the implementation, we used the R package “glmnet” (39).

PROVAR was defined for each of the 222 TCGA samples as the sum of the estimated coefficients multiplied by protein expression levels, as shown below. Here i represents patients (i = 1, ..., 222), j represents proteins with nonzero coefficients (j = 1, ..., m), β̂j is the lasso coefficient of the jth protein marker, and Xij is the expression level of the jth protein for the ith patient.

graphic file with name JCI74035.e2.jpg

(Equation 2)

The JCI regrets the error.


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES